Medicamen Biotech Limited share price
NSE: MEDICAMEQ · ISIN INE646B01010
Key numbers
- Market cap
- ₹ 428 Cr
- Current price
- ₹ 315.30
- 52-week high / low
- ₹ 448 / 212
- Stock P/E
- 43.3
- Book value
- ₹ 234.3
- Dividend yield
- 0.32%
- ROCE
- 5.4%
- ROE
- 4.0%
- Debt to equity
- 0.17
- Sales growth (3 yrs)
- 12.0%
- Profit growth (3 yrs)
- -13.4%
- 1-year return
- -5.4%
About Medicamen Biotech Limited
Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 43 | 47 | 47 | 61 | 48 |
| Operating profit | 5 | 5 | 4 | 5 | 4 |
| Net profit | 2 | 3 | 2 | 4 | 2 |
| EPS (₹) | 1.18 | 1.56 | 1.21 | 3.28 | 1.36 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.